BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10171477)

  • 1. Perspectives. Good-bye, Hawaii: changes ahead in corporate-backed CME.
    Moskowitz DB
    Faulkner Grays Med Health; 1993 Jul; 47(29):suppl 4 p.. PubMed ID: 10171477
    [No Abstract]   [Full Text] [Related]  

  • 2. Commercial support and continuing medical education.
    Steinbrook R
    N Engl J Med; 2005 Feb; 352(6):534-5. PubMed ID: 15703417
    [No Abstract]   [Full Text] [Related]  

  • 3. Future directions in industry funding of continuing medical education.
    Steinbrook R
    Arch Intern Med; 2011 Feb; 171(3):257-8. PubMed ID: 21325116
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for faculty involvement in commercially supported continuing medical education. AAMC Ad Hoc Committee on Misconduct and Conflict of Interest in Research. AAMC Subcommittee on Conflict of Interest in Continuing Medical Education.
    Acad Med; 1992 Sep; 67(9):615-21. PubMed ID: 1520428
    [No Abstract]   [Full Text] [Related]  

  • 5. There is a role for industry-sponsored education in cardiology.
    Harrington RA; Califf RM
    Circulation; 2010 May; 121(20):2221-7. PubMed ID: 20497985
    [No Abstract]   [Full Text] [Related]  

  • 6. AMA forges ahead. Unveiling of educational campaign paid by drug industry triggers new criticism.
    Romano M
    Mod Healthc; 2001 Sep; 31(37):22-3. PubMed ID: 11573355
    [No Abstract]   [Full Text] [Related]  

  • 7. A risk stratification tool to assess commercial influences on continuing medical education.
    Barnes BE; Cole JG; King CT; Zukowski R; Allgier-Baker T; Rubio DM; Thorndyke LE
    J Contin Educ Health Prof; 2007; 27(4):234-40. PubMed ID: 18085603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.
    Rosner F
    Mt Sinai J Med; 1995 Nov; 62(6):427-30. PubMed ID: 8692156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial relationships with industry and device research involving non-Food and Drug Administration-approved use: a perspective.
    Becker GJ
    Radiology; 2006 Jun; 239(3):626-8. PubMed ID: 16714453
    [No Abstract]   [Full Text] [Related]  

  • 10. Safeguarding Physician Education From Inappropriate Influence.
    McMahon GT
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):261-262. PubMed ID: 29726351
    [No Abstract]   [Full Text] [Related]  

  • 11. Gifts to physicians from the pharmaceutical and medical manufacturing industry: what every physician should know.
    Zoorob R; Larzelere M
    J La State Med Soc; 2004; 156(1):28-32. PubMed ID: 15000210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues of conflict resolution. Critics ask why council backed off tighter restrictions.
    Rhea S
    Mod Healthc; 2009 Aug; 39(31):8-9. PubMed ID: 19688888
    [No Abstract]   [Full Text] [Related]  

  • 13. Conflict of interest in CME.
    Nelson R
    Iowa Med; 1994 Dec; 84(12):541. PubMed ID: 7843923
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of industry support on participants' perceptions of bias in continuing medical education.
    Kawczak S; Carey W; Lopez R; Jackman D
    Acad Med; 2010 Jan; 85(1):80-4. PubMed ID: 20042829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual wariness needed to spot biased drug research.
    Lazarus A
    Manag Care; 2005 Sep; 14(9):8, 13. PubMed ID: 16238253
    [No Abstract]   [Full Text] [Related]  

  • 16. Commercial support and the quandary of continuing medical education.
    Schaffer MH
    J Contin Educ Health Prof; 2000; 20(2):120-6. PubMed ID: 11232220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does industry have a role in medical education?
    Pellman H
    Arch Intern Med; 2011 Aug; 171(15):1404. PubMed ID: 21824965
    [No Abstract]   [Full Text] [Related]  

  • 18. Current guidelines regarding industry-sponsored continuing medical education.
    DelSignore JL
    Clin Orthop Relat Res; 2003 Jul; (412):21-7. PubMed ID: 12838047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The agenda for continuing medical education--limiting industry's influence.
    Morris L; Taitsman JK
    N Engl J Med; 2009 Dec; 361(25):2478-82. PubMed ID: 20018969
    [No Abstract]   [Full Text] [Related]  

  • 20. Industry support of CME--are we at the tipping point?
    Steinman MA; Landefeld CS; Baron RB
    N Engl J Med; 2012 Mar; 366(12):1069-71. PubMed ID: 22435367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.